作者：Xuan Zhang*, Yi-Chi Zhang, Li-Xia Ma.
关键字：Graphene; Zinc oxide; Ascorbic acid; Dopamine; Uric acid; Electrochemical biosensor
论文来源：期刊
具体来源：Sens. Actuator B, 2016, 227, 488–496
发表时间：2016年
Reduced graphene oxide-zinc oxide (RGO–ZnO) composite was facilely fabricated by a spontaneous reduction of graphene oxide via zinc slice in one-pot approach at room temperature, and used to modify glassy carbon electrode (GCE) for developing of electrochemical biosensor (RGO–ZnO/GCE). The as-prepared RGO–ZnO was characterized by X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), inductively coupled plasma atomic emission spectroscopy (ICP-AES), scanning electron microscopy (SEM) and transmission electron microscope (TEM). It was revealed that the existence of ZnO in RGO–ZnO/GCE largely enhanced the electroactive surface area (EASA) and therefore the sensitivity for electrochemical sensing. In the mixtures of ascorbic acid (AA), dopamine (DA) and uric acid (UA), the biosensor exhibited three well-resolved voltammetric peaks (ΔEAA–DA = 236 mV, ΔEDA–UA = 132 mV, ΔEAA–UA = 368 mV) in the differential pulse voltammetry (DPV) measurements, allowing a simultaneous electrochemical detection of these biomolecules. The liner relationships between current intensities and concentrations were found to be 50–2350 μM, 1–70 μM and 3–330 μM, with detection limits of 3.71 μM, 0.33 μM and 1.08 μM for AA, UA and DA, respectively. The as-prepared RGO–ZnO/GCE biosensor displayed a good reproducibility and stability and was applied for detection of of AA, DA and UA in real plasma and urine samples with satisfying results.